These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15670876)

  • 41. Predicting uptake of MMR vaccination: a prospective questionnaire study.
    Flynn M; Ogden J
    Br J Gen Pract; 2004 Jul; 54(504):526-30. PubMed ID: 15239915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tracking mothers' attitudes to MMR immunisation 1996-2006.
    Smith A; Yarwood J; Salisbury DM
    Vaccine; 2007 May; 25(20):3996-4002. PubMed ID: 17395344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Socio-demographic and health-related predictors of uptake of first MMR immunisation in the Lifeways Cohort Study.
    Jessop LJ; Murrin C; Lotya J; Clarke AT; O'Mahony D; Fallon UB; Johnson H; Bury G; Kelleher CC; Murphy AW;
    Vaccine; 2010 Aug; 28(38):6338-43. PubMed ID: 20637302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK; Chiu YL; Wilkin T
    AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
    [No Abstract]   [Full Text] [Related]  

  • 49. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K; Bunce A
    Epidemiol Infect; 2012 Sep; 140(9):1612-6. PubMed ID: 22117122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Informing education policy on MMR: balancing individual freedoms and collective responsibilities for the promotion of public health.
    Wood-Harper J
    Nurs Ethics; 2005 Jan; 12(1):43-58. PubMed ID: 15685967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Measles, mumps, rubella: important health risks].
    Rev Infirm; 2000 Oct; (64):13-5. PubMed ID: 11288443
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with poor adherence to MMR vaccination in parents who follow vaccination schedule.
    Restivo V; Napoli G; Marsala MG; Bonanno V; Sciuto V; Amodio E; Calamusa G; Vitale F; Firenze A
    Hum Vaccin Immunother; 2015; 11(1):140-5. PubMed ID: 25483527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MMR vaccine uptake rates: a data validation study.
    Ghebrehewet S; Falconer M; McDonald P; Schlecht B
    Commun Dis Public Health; 2003 Jun; 6(2):144-6. PubMed ID: 12889295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MMR vaccination: answers to some parents' questions.
    Moreton J
    J Fam Health Care; 2002; 12(6):151-3. PubMed ID: 12630143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. London's catch-up vaccination campaign against measles, mumps, and rubella reaches less than a quarter of children who were unvaccinated.
    Hitchen L
    BMJ; 2008 Sep; 337():a1797. PubMed ID: 18815174
    [No Abstract]   [Full Text] [Related]  

  • 58. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MMR immunisation status among Dublin paediatric A&E attenders.
    Murphy AW; Power R; Kinlen DM; Johnson Z
    Ir Med J; 1994; 87(2):40-2. PubMed ID: 8194951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.